Evidence map›Paper›PMID 41519883›Full record

Observational studyScientific reports2026

T-cell biomarkers improve urinary tract infection risk stratification beyond clinical characteristics after acute traumatic spinal cord injury.

Oliver Schweizerhof, Christian Meisel, Christian Blex, Paolo Cinelli, Ralf Watzlawick, Tom Lübstorf, Laura-Christin Geurtz, Martin Kreutzträger, Elias Baumgartner, Julian Hirt and 16 more

Abstract readObservational Study
In one paragraph

Observational study in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Oliver SchweizerhofInstitute of Biometry and Clinical Epidemiology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany. oliver.schweizerhof@charite.de.
Christian MeiselInstitute of Medical Immunology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.
Christian BlexSpinal Cord Injury Research (Neuroparaplegiology), Department of Neurology and Experimental Neurology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.
Paolo CinelliDepartment of Trauma Surgery, University Hospital Zurich, University of Zurich, Raemistr. 100, 8091, Zurich, Switzerland.
Ralf WatzlawickSpinal Cord Injury Research (Neuroparaplegiology), Department of Neurology and Experimental Neurology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.
Tom LübstorfSpinal Cord Injury Research (Neuroparaplegiology), Department of Neurology and Experimental Neurology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.
Laura-Christin GeurtzSpinal Cord Injury Research (Neuroparaplegiology), Department of Neurology and Experimental Neurology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.
Martin KreutzträgerTreatment Centre for Spinal Cord Injuries, BG Hospital Unfallkrankenhaus Berlin, Warener Straße 7, 12683, Berlin, Germany.
Elias BaumgartnerSpinal Cord Injury Research (Neuroparaplegiology), Department of Neurology and Experimental Neurology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.
Julian HirtSpinal Cord Injury Research (Neuroparaplegiology), Department of Neurology and Experimental Neurology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.
Magdalena HoppeSpinal Cord Injury Research (Neuroparaplegiology), Department of Neurology and Experimental Neurology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.
Nadine UnterwalderDepartment of Immunology, Labor Berlin - Charité Vivantes GmbH, Sylter Strasse 2, 13353, Berlin, Germany.
Uwe KölschDepartment of Immunology, Labor Berlin - Charité Vivantes GmbH, Sylter Strasse 2, 13353, Berlin, Germany.
Ralf BöthigDepartment of Neuro-Urology, Centre for Spinal Cord Injuries, BG Klinikum Hamburg, Hamburg, Germany.
Burkhard DomurathCenter for Neuro-Urology, Kliniken Beelitz, Paracelsusring 6a, 14547, Beelitz-Heilstätten, Germany.
Claudia DruschelMedical Advisory Service Berlin-Brandenburg, Schlaatzweg 1, 14473, Potsdam, Germany.
Klaus-Dieter SchaserDepartment of Orthopaedic and Trauma Surgery, Universitätsklinikum Carl-Gustav Carus, Dresden, Germany.
Andreas NiedeggenTreatment Centre for Spinal Cord Injuries, BG Hospital Unfallkrankenhaus Berlin, Warener Straße 7, 12683, Berlin, Germany.
Armin CurtSpinal Cord Injury Center, University Hospital Balgrist, Forchstrasse 340, 8008, Zurich, Switzerland.
Michael G FehlingsDivision of Neurosurgery, Department of Surgery, University of Toronto, 149 College Street, Toronto, ON, M5T 1P5, Canada.
Peter VajkoczyDepartment of Neurosurgery, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.
Axel EkkernkampTrauma Surgery and Orthopedics Clinic, BG Hospital Unfallkrankenhaus Berlin, Warener Straße 7, 12683, Berlin, Germany.
Thomas LiebscherClinic for Trauma Surgery, Orthopaedics and Specialized Septic Surgery, Klinikum St. Georg gGmbH, Delitzscher Strasse 141, 04129, Leipzig, Germany.
Jan M SchwabSpinal Cord Injury Research (Neuroparaplegiology), Department of Neurology and Experimental Neurology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.
Marcel A KoppSpinal Cord Injury Research (Neuroparaplegiology), Department of Neurology and Experimental Neurology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany. marcel.kopp@charite.de.
Ulrike GrittnerInstitute of Biometry and Clinical Epidemiology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with traumatic spinal cord injury (SCI) frequently develop urinary tract infections (UTI) which may compromise neurological rehabilitation. We explored risk factors for UTI, including immunological biomarkers, in patients with acute traumatic SCI during the transition from acute to subacute phase. Two observational studies were analysed separately: a retrospective study (COaT-SCI, n = 296, follow-up 13 weeks), and a prospective immunological study (SCIentinel, n = 70, follow-up 10 weeks). Cox regression models were used to examine associations of first UTI with patient characteristics and longitudinal immunological parameters. Cumulative incidence of first UTI was approximately 50% at six weeks. Results indicated higher UTI risk in older patients and time-varying associations for SCI severity (ASIA impairment scale) and presence of accompanying injuries. Higher cellular immune competence, particularly CD8 + T-cell counts and higher IFN-γ/IL-4 ratio in functional T-cell assays, were associated with a lower UTI risk (HR [95% CI] per log-transformed unit: CD8 + T-cells 0.34 [0.18-0.65], IFN-γ/IL-4 ratio 0.53 [0.33-0.83]). Adding cellular immune markers improved models' discriminative ability (weighted C-index at 21 days from 0.68 to 0.76 with CD8 + T-cells). These findings indicate UTI is facilitated by systemic immune alterations, with T-cell parameters representing promising predictive biomarkers requiring further validation before clinical implementation.

Indexed as

CD8-Positive T-LymphocytesSpinal Cord InjuriesT-LymphocytesUrinary Tract InfectionsAdultAgedBiomarkersFemaleHumansInterferon-gammaInterleukin-4MaleMiddle AgedProspective StudiesRetrospective StudiesRisk AssessmentBiomarkersInterferon-gammaInterleukin-4Cellular immunityNeurogenic bladderRisk factorsSpinal cord injuryT LymphocytesUrinary tract infections

Identifiers

PMID41519883
PMCPMC12796231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.